Skip to main content
    E

    Evogene (EVGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    +0.02 (+5.58%)

    Market Cap: $6.70M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Evogene (EVGN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Evogene are Soligenix (SNGX), GT Biopharma (GTBP) and In8bio (INAB). By market cap, Evogene ranks 10th of the 13 companies on this page; Vyome Holdings (HIND) is the largest at $11.09M.

    Peer Comparison

    EVGN's revenue growth of -60.7% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Evogene (EVGN)$6.70MN/A3.7x0.0%N/A-60.7%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    GT Biopharma Inc (GTBP)$7.67MN/AN/A0.0%N/A0.0%0.00%
    In8bio Inc (INAB)$8.86MN/AN/A0.0%N/A0.0%0.00%
    Senti Biosciences Inc (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Ensysce Biosciences Inc (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    VistaGen Therapeutics Inc (VTGN)$8.01MN/A3.4x0.0%N/A-46.5%0.00%
    Exicure Inc (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    Vyome Holdings, Inc. (HIND)$11.09MN/AN/A0.0%N/A67.5%0.00%
    Theriva Biologics Inc. (TOVX)$6.61MN/A21.5x0.0%-52.3%0.0%0.00%
    Moleculin Biotech Inc (MBRX)$8.02MN/AN/A0.0%N/A0.0%0.00%
    Galmed Pharmaceuticals Ltd (GLMD)$4.95MN/AN/A0.0%N/A0.0%N/A
    Longeveron LLC (LGVN)$8.40MN/A5.9x0.0%N/A-9.2%0.00%
    Peer median$7.84MN/A5.9x0.0%-52.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Evogene, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    GT Biopharma Inc (GTBP)
    GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its...
    GTBP competitors
    In8bio Inc (INAB)
    IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers...
    INAB competitors
    Senti Biosciences Inc (SNTI)
    Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology...
    SNTI competitors
    Ensysce Biosciences Inc (ENSC)
    Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs.
    ENSC competitors
    VistaGen Therapeutics Inc (VTGN)
    VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential...
    VTGN competitors
    Exicure Inc (XCUR)
    Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases...
    XCUR competitors
    Vyome Holdings, Inc. (HIND)
    Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States...
    HIND competitors
    Theriva Biologics Inc. (TOVX)
    Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need.
    TOVX competitors
    Moleculin Biotech Inc (MBRX)
    Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant...
    MBRX competitors
    Galmed Pharmaceuticals Ltd (GLMD)
    Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases.
    Longeveron LLC (LGVN)
    Longeveron Inc., a clinical-stage biotechnology company, is dedicated to developing cell therapies for life-threatening and aging-related conditions.
    LGVN competitors

    Frequently Asked Questions About EVGN

    Who are Evogene's main competitors?

    The companies most similar to Evogene include Soligenix (SNGX), GT Biopharma (GTBP), In8bio (INAB), Senti Biosciences (SNTI) and Ensysce Biosciences (ENSC), listed from the closest match.

    Who is Evogene's biggest competitor?

    Vyome Holdings (HIND) is the largest of the similar companies at $11.09M; Soligenix (SNGX) is the closest match by business profile, size, sector and industry.

    How does EVGN stock compare with its competitors?

    EVGN's P/S is 3.7x against a peer median of 5.9x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Evogene's competitors pays a higher dividend?

    Evogene pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Evogene bigger than its competitors?

    No. Evogene is 10th by market cap among the 13 companies on this page; the largest is Vyome Holdings (HIND) at $11.09M.